Including results for esperion investor relations
Search only for espr investor relations
The Investor Relations website contains information about Esperion Therapeutics, Inc.'s business for stockholders, potential investors, and financial ...
The Investor Relations website contains information about Esperion Therapeutics, Inc.'s business for stockholders, potential investors, and financial ...
People also ask
Is Esperion owned by Pfizer?
Is ESPR a good buy?
Is Esperion Therapeutics a good company to work for?
Who are the shareholders of Esperion?
3 hours ago · ... ESPR) today announced it will report first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024 ... investor-relations/ ...
Esperion Therapeutics, Inc. Common Stock is estimated to report earnings on 05/14/2024. The upcoming earnings date is derived from an algorithm based on a ...
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Feb 27, 2024 · (NASDAQ:ESPR) Q4 2023 Earnings Conference Call February 27, 2024 8:00 AM ET. Company Participants. Alexis Callahan - Head of Investor Relations
Feb 28, 2024 · I would now like to hand the conference over to Alexis Callahan, Head of Investor Relations. Please go ahead. ADVERTISEMENT. Advertisement.
2022 Q2 - Results - Earnings Call Presentation · SA TranscriptsTue, Aug. 02, 20221 Comment · Esperion Therapeutics (ESPR) Investor Presentation - Slideshow · SA ...
Missing: relations | Show results with:relations
See the latest Esperion Therapeutics Inc stock price (ESPR:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
$1.41
Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments ...